Evidence map›Paper›PMID 40464580›Full record

ArticleJournal of virology2025

Interferon-stimulated gene MCL1 inhibits foot-and-mouth disease virus replication by modulating mitochondrial dynamics and autophagy.

Aishwarya Mogulothu, Danielle Hickman, Sarah Attreed, Paul Azzinaro, Monica Rodriguez-Calzada, Meike Dittmann, Teresa de Los Santos, Steven Szczepanek, Gisselle N Medina

Abstract read
In one paragraph

Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aishwarya MogulothuDepartment of Pathobiology and Veterinary Science, University of Connecticut, Storrs, Connecticut, USA.
Danielle HickmanMillipore Sigma, Indianapolis, Indiana, USA.
Sarah AttreedForeign Animal Disease Research Unit, Plum Island Animal Disease Center, Agricultural Research Service, U.S. Department of Agriculture, Greenport, New York, USA.
Paul AzzinaroForeign Animal Disease Research Unit, Plum Island Animal Disease Center, Agricultural Research Service, U.S. Department of Agriculture, Greenport, New York, USA.
Monica Rodriguez-CalzadaForeign Animal Disease Research Unit, Plum Island Animal Disease Center, Agricultural Research Service, U.S. Department of Agriculture, Greenport, New York, USA.
Meike DittmannDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.ORCID 0000-0002-1741-7916
Teresa de Los SantosForeign Animal Disease Research Unit, Plum Island Animal Disease Center, Agricultural Research Service, U.S. Department of Agriculture, Greenport, New York, USA.
Steven SzczepanekDepartment of Pathobiology and Veterinary Science, University of Connecticut, Storrs, Connecticut, USA.
Gisselle N MedinaForeign Animal Disease Research Unit, Plum Island Animal Disease Center, Agricultural Research Service, U.S. Department of Agriculture, Greenport, New York, USA.ORCID 0000-0002-8663-3786

Funding

U.S. Department of Agriculture USDA ARS-CRIS Project 501-3022-505-064-00D, USDA-ARS NACA 58-8064-9-011
6 · The paper itself

Abstract

Interferons (IFNs) and the IFN-stimulated genes (ISGs) that they induce are effective in reducing the replication of foot and mouth disease virus (FMDV). The use of a high-throughput ISG screen identified the ISG myeloid cell leukemia 1 (MCL1) as an ISG with an antiviral effect against an FMDV replicon system. In this study, we demonstrated that overexpression of MCL1 inhibits FMDV replication by reducing approximately 4 logs of virus titers in porcine cells. We then explored the regulatory pathways associated with MCL1 to determine the specific antiviral mechanisms against FMDV. Our findings indicated that the antiviral mechanism does not involve apoptosis regulation or alterations in cell cycle phase heterogeneity. Analysis of mitochondrial function, through measurement of mitochondrial oxygen consumption rate, demonstrated that overexpression of MCL1 results in increased mitochondrial respiration and ATP production, whereas FMDV infection reduces both processes. Moreover, MCL1 overexpression resulted in elongated mitochondrial morphology, contrasting with the fragmented and punctate morphology observed during FMDV infection. Importantly, these changes in mitochondrial dynamics were independent of MCL1's regulation of mitochondrial calcium flux. We also found that MCL1 overexpression suppresses autophagy, which is known to be necessary for FMDV replication. Our data indicate that MCL1 is a potent antiviral ISG against FMDV and highlight the importance of mitochondrial dynamics and autophagy in FMDV replication.IMPORTANCEIn this study, we have successfully used a high-throughput ISG screening approach to measure the inhibition of FMDV replication using an RNA replicon system for the first time. This screen led to the identification of the potent antiviral effects of a relatively lesser-known ISG called MCL1. Our findings reveal that MCL1 exerts its antiviral functions through the regulation of mitochondrial dynamics and autophagy. Although mitochondrial dynamics are involved in apoptosis, metabolism, redox homeostasis, stress responses, and antiviral signaling, this pathway has not been thoroughly explored in the context of FMDV infection. Further investigation into mitochondrial dynamics may facilitate the development of improved biotherapeutics for FMDV. Additionally, our studies highlight the significance of autophagy, a pathway that is needed by FMDV for replication. Ultimately, a deep understanding of all mechanisms exploited by FMDV may allow for the rational design of novel therapeutics and vaccines to control FMD.

Indexed as

AutophagyFoot-and-Mouth DiseaseFoot-and-Mouth Disease VirusInterferonsMitochondrial DynamicsMyeloid Cell Leukemia Sequence 1 ProteinVirus ReplicationAnimalsCell LineMitochondriaSwineInterferonsMyeloid Cell Leukemia Sequence 1 Proteinantiviral agentsautophagyfoot-and-mouth disease virusinterferonsinterferon-stimulated genesmitochondrial metabolism

Identifiers

PMID40464580
PMCPMC12282159

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.